InvestWiser

ScandiDos AB

SDOSNasdaq StockholmHealthcareMarket value 30 m SEK
0.42SEK 0.0%
last day · Price as of 18 November 2026

The answer first

Does ScandiDos beat the market?

No, ScandiDos has not beaten the market over the last year.

ScandiDos−60.2%Stockholm (OMXSGI)+18.7%
  • The ranking · Quality, value and trend combined

    Better than 18% of Nordic stocks

    • Quality22
    • Value74
    • Trend4

    No. 134 of 195 in healthcare

Max for seven days

Follow ScandiDos with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on ScandiDos

From today, at a price of 0.42 SEK. Write why you follow ScandiDos, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about ScandiDos

Your first answer is free, no account needed.

Do you own ScandiDos, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with ScandiDos and a few more. Free, no card.

Past year against the exchange and Super Stock
ScandiDos−60.2%Stockholm (OMXSGI)+18.7%Super Stock+45.9%
13 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • ScandiDos has fallen 60.2% over the past year, including dividends.
  • Overall, ScandiDos ranks better than 18% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 82.6%. The price is 97.0% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

18

Quality, value and trend together. Better than 18% of Nordic stocks.

No. 134 of 195 in healthcare

Quality22
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 166 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.05
  • Asset turnoverSales divided by everything the company owns0.69
  • Return on equityProfit divided by equity−17.4%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value74
The price · Valuation: the multiples

High Low price: you pay little for what the company earns and owns.

No. 17 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity0.5
  • P/SPrice divided by sales0.5
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend4
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 183 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−52.0%
  • 6 months−59.2%
  • 9 months−57.9%
  • 12 months−60.2%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−29.4%
3 years, per year
−39.5%
5 years, per year
−33.3%
10 years, per year
−20.7%
Largest fall, 3 years
−82.6%
From a peak to the bottom
From the peak now
−97.0%
How far the price is from the peak
Volatility, 1 year
44.0%
How much the price swings over a year
Beta, 1 year
0.09
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own ScandiDos

One fund we follow owns ScandiDos. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About ScandiDos

ScandiDos AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 25 employees.

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and advanced software solutions in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+ and Delta4Phantom+MR; Delta4 HexaMotion; and Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, including VMAT, RapidArc, IMRT, and tomotherapy. It also provides installation services, service agreements, and additional services. It sells its products through sales offices and distributors.

See the full analysis of ScandiDos.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market